Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of JY09 in Healthy Subjects
NCT02971722Phase 1Unknown
- Sponsor
- Beijing Dongfang Biotech Co., Ltd.
- Start
- Dec 2016
- Primary completion
- May 2017
- Modality
- Fc-Fusion Proteins
01
Overview
Phase 1, randomised, double-blind trial of JY-09 in type 2 diabetes mellitus (T2DM) (8 cohorts), sponsored by Beijing Dongfang Biotech Co., Ltd. Primary endpoint: Pharmacokinetics. Status: unknown.
02
Drugs
JY-09
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02971722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02971722.